Literature DB >> 27548081

Treatment of Non-Alcoholic Fatty Liver Disease.

Antonia Scherer1, Jean-François Dufour.   

Abstract

Non-alcoholic fatty liver disease (NAFLD) encompasses a spectrum of conditions from steatosis to cirrhosis and hepatocellular carcinoma. Steatosis is a benign reversible condition, which does not need treatment. Cirrhosis and hepatocellular carcinoma are the end stages of any chronic liver disease and do not have etiology-specific treatments. In this chapter, we will review treatment options for non-alcoholic steatohepatitis, which is the progressive form of NAFLD. Basically there are 2 strategies, the first of which is to address lifestyle and the second to use medication. The first approach is the most physiologic, the least expensive, but is also the most difficult to implement. The second approach, which should help patients who failed the first approach, is at the advanced clinical research stage.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27548081     DOI: 10.1159/000447278

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  5 in total

Review 1.  Nonalcoholic Fatty Liver Disease Among Individuals with HIV Mono-infection: A Growing Concern?

Authors:  Margaret Morrison; Heather Y Hughes; Susanna Naggie; Wing-Kin Syn
Journal:  Dig Dis Sci       Date:  2019-10-23       Impact factor: 3.199

2.  Gemcabene downregulates inflammatory, lipid-altering and cell-signaling genes in the STAM™ model of NASH.

Authors:  Daniela Carmen Oniciu; Taishi Hashiguchi; Yuichiro Shibazaki; Charles L Bisgaier
Journal:  PLoS One       Date:  2018-05-30       Impact factor: 3.240

3.  Impact of Non-alcoholic Fatty Liver Disease on long-term cardiovascular events and death in Chronic Obstructive Pulmonary Disease.

Authors:  Damien Viglino; Anais Plazanet; Sebastien Bailly; Meriem Benmerad; Ingrid Jullian-Desayes; Renaud Tamisier; Vincent Leroy; Jean-Pierre Zarski; Maxime Maignan; Marie Joyeux-Faure; Jean-Louis Pépin
Journal:  Sci Rep       Date:  2018-11-08       Impact factor: 4.379

4.  Normothermic Ex Vivo Liver Platform Using Porcine Slaughterhouse Livers for Disease Modeling.

Authors:  Melanie Krüger; Alicia Ruppelt; Benjamin Kappler; Elke Van Soest; Roos Anne Samsom; Guy C M Grinwis; Niels Geijsen; J Bernd Helms; Marco Stijnen; Linda M Kock; Marco Rasponi; Hans S Kooistra; Bart Spee
Journal:  Bioengineering (Basel)       Date:  2022-09-14

5.  High level of polarized engraftment of porcine intrahepatic cholangiocyte organoids in decellularized liver scaffolds.

Authors:  Melanie Krüger; Roos-Anne Samsom; Loes A Oosterhoff; Monique E van Wolferen; Hans S Kooistra; Niels Geijsen; Louis C Penning; Linda M Kock; Pilar Sainz-Arnal; Pedro M Baptista; Bart Spee
Journal:  J Cell Mol Med       Date:  2022-08-26       Impact factor: 5.295

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.